103 related articles for article (PubMed ID: 29813026)
1. Exploring the role of defective fibronectin matrix assembly in the VHL-associated CNS hemangioblastoma.
Vikkath N; Ariyannur P; Menon KN; Mr B; Pillai A
Drug Metab Pers Ther; 2018 Sep; 33(3):127-134. PubMed ID: 29813026
[No Abstract] [Full Text] [Related]
2. Molecularly genetic analysis of von Hippel-Lindau associated central nervous system hemangioblastoma.
Zhou J; Wang J; Li N; Zhang X; Zhou H; Zhang R; Ma H; Zhou X
Pathol Int; 2010 Jun; 60(6):452-8. PubMed ID: 20518900
[TBL] [Abstract][Full Text] [Related]
3. Role of VHL-JAK-STAT signaling pathway in central nervous system hemangioblastoma associated with von Hippel-Lindau disease.
Kanno H; Yoshizumi T; Shinonaga M; Kubo A; Murata H; Yao M
J Neurooncol; 2020 May; 148(1):29-38. PubMed ID: 32356150
[TBL] [Abstract][Full Text] [Related]
4. Genotype-phenotype analysis of von Hippel-Lindau syndrome in Korean families: HIF-α binding site missense mutations elevate age-specific risk for CNS hemangioblastoma.
Lee JS; Lee JH; Lee KE; Kim JH; Hong JM; Ra EK; Seo SH; Lee SJ; Kim MJ; Park SS; Seong MW
BMC Med Genet; 2016 Jul; 17(1):48. PubMed ID: 27439424
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a von Hippel Lindau pathway involved in extracellular matrix remodeling, cell invasion, and angiogenesis.
Kurban G; Hudon V; Duplan E; Ohh M; Pause A
Cancer Res; 2006 Feb; 66(3):1313-9. PubMed ID: 16452184
[TBL] [Abstract][Full Text] [Related]
6. The von Hippel-Lindau tumor suppressor protein is required for proper assembly of an extracellular fibronectin matrix.
Ohh M; Yauch RL; Lonergan KM; Whaley JM; Stemmer-Rachamimov AO; Louis DN; Gavin BJ; Kley N; Kaelin WG; Iliopoulos O
Mol Cell; 1998 Jun; 1(7):959-68. PubMed ID: 9651579
[TBL] [Abstract][Full Text] [Related]
7. The β2-adrenergic receptor antagonist ICI-118,551 blocks the constitutively activated HIF signalling in hemangioblastomas from von Hippel-Lindau disease.
Cuesta AM; Albiñana V; Gallardo-Vara E; Recio-Poveda L; de Rojas-P I; de Las Heras KVG; Aguirre DT; Botella LM
Sci Rep; 2019 Jul; 9(1):10062. PubMed ID: 31296894
[TBL] [Abstract][Full Text] [Related]
8. [Von Hippel-Lindau syndrome - a case report].
Figlus M; Kaczorowska B; Jaskólski DJ; Kępczyński Ł
Pol Merkur Lekarski; 2018 May; 44(263):248-252. PubMed ID: 29813043
[TBL] [Abstract][Full Text] [Related]
9. Extraneuraxial hemangioblastoma: A clinicopathologic study of 10 cases with molecular analysis of the VHL gene.
Muscarella LA; Bisceglia M; Galliani CA; Zidar N; Ben-Dor DJ; Pasquinelli G; la Torre A; Sparaneo A; Fanburg-Smith JC; Lamovec J; Michal M; Bacchi CE
Pathol Res Pract; 2018 Aug; 214(8):1156-1165. PubMed ID: 29941223
[TBL] [Abstract][Full Text] [Related]
10. Inadequate activation of the GTPase RhoA contributes to the lack of fibronectin matrix assembly in von Hippel-Lindau protein-defective renal cancer cells.
Feijóo-Cuaresma M; Méndez F; Maqueda A; Esteban MA; Naranjo-Suarez S; Castellanos MC; del Cerro MH; Vazquez SN; García-Pardo A; Landázuri MO; Calzada MJ
J Biol Chem; 2008 Sep; 283(36):24982-90. PubMed ID: 18567581
[TBL] [Abstract][Full Text] [Related]
11. A Case of von Hippel-Lindau Disease with Colorectal Adenocarcinoma, Renal Cell Carcinoma and Hemangioblastomas.
Heo SJ; Lee CK; Hahn KY; Kim G; Hur H; Choi SH; Han KS; Cho A; Jung M
Cancer Res Treat; 2016 Jan; 48(1):409-14. PubMed ID: 25715769
[TBL] [Abstract][Full Text] [Related]
12. Von hippel-lindau disease: a genetic and clinical review.
Haddad NM; Cavallerano JD; Silva PS
Semin Ophthalmol; 2013; 28(5-6):377-86. PubMed ID: 24138046
[TBL] [Abstract][Full Text] [Related]
13. A novel mutation links to von Hippel-Lindau syndrome in a Chinese family with hemangioblastoma.
Fu XM; Zhao SL; Gui JC; Jiang YQ; Shen MN; Su DL; Gu BJ; Wang XQ; Ren QJ; Yin XD; Huang WB; Chen XG
Genet Mol Res; 2015 May; 14(2):4513-20. PubMed ID: 25966224
[TBL] [Abstract][Full Text] [Related]
14. CNS hemangioblastomatosis in a patient without von Hippel-Lindau disease.
Franco A; Pytel P; Lukas RV; Chennamaneni R; Collins JM
CNS Oncol; 2017 Apr; 6(2):101-105. PubMed ID: 28425756
[TBL] [Abstract][Full Text] [Related]
15. Nervous system involvement in von Hippel-Lindau disease: pathology and mechanisms.
Vortmeyer AO; Falke EA; Gläsker S; Li J; Oldfield EH
Acta Neuropathol; 2013 Mar; 125(3):333-50. PubMed ID: 23400300
[TBL] [Abstract][Full Text] [Related]
16. Developmental effects of von Hippel-Lindau gene deficiency.
Vortmeyer AO; Yuan Q; Lee YS; Zhuang Z; Oldfield EH
Ann Neurol; 2004 May; 55(5):721-8. PubMed ID: 15122713
[TBL] [Abstract][Full Text] [Related]
17. Expression of fibronectin and HIF-1alpha in renal cell carcinomas: relationship to von Hippel-Lindau gene inactivation.
He Z; Liu S; Guo M; Mao J; Hughson MD
Cancer Genet Cytogenet; 2004 Jul; 152(2):89-94. PubMed ID: 15262424
[TBL] [Abstract][Full Text] [Related]
18. [Clinicopathologic study of von Hippel-Lindau syndrome-related and sporadic hemangioblastomas of central nervous system].
Zhou J; Li NY; Zhou XJ; Zhou HB; Wu B; Jiang SJ; Ma HH; Zhang RS
Zhonghua Bing Li Xue Za Zhi; 2010 Mar; 39(3):145-50. PubMed ID: 20450758
[TBL] [Abstract][Full Text] [Related]
19. Von Hippel-Lindau disease: a single gene, several hereditary tumors.
Crespigio J; Berbel LCL; Dias MA; Berbel RF; Pereira SS; Pignatelli D; Mazzuco TL
J Endocrinol Invest; 2018 Jan; 41(1):21-31. PubMed ID: 28589383
[TBL] [Abstract][Full Text] [Related]
20. [Genetic analysis of a family with Von Hippel-Lindau syndrome].
Lafuente-Sanchis A; Cuevas JM; Alemany P; Cremades A; Zúñiga Á
Rev Esp Patol; 2017; 50(1):64-67. PubMed ID: 29179968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
